Literature DB >> 11684927

Differences in early virus loads with different phenotypic variants of HIV-1 and SIV(cpz) in chimpanzees.

P ten Haaft1, K Murthy, M Salas, H McClure, R Dubbes, W Koornstra, H Niphuis, D Davis, G van der Groen, J Heeney.   

Abstract

OBJECTIVE: A comparative study of the replication kinetics of different HIV-1 variants (including SIV(cpz)) was undertaken to determine which viral characteristics were associated with sustained plasma viraemia in chimpanzees.
DESIGN: Plasma samples from chimpanzees infected with six different HIV-1 clade B isolates were compared with plasma samples from SIV(cpz-ant)-infected chimpanzees.
METHODS: A pan-clade quantitative competitive reverse transcriptase-polymerase chain reaction assay was developed based on conserved primer sequences recognizing M, N and O human lentiviruses as well as different SIV(cpz) isolates.
RESULTS: Important differences between early kinetics in the human lentivirus isolates as well as compared with the chimpanzee isolate SIV(cpz-ant) were observed. R5-dependent non-syncytium-inducing (NSI) isolates (5016, Ba-L, SIV(cpz)) were found to have relatively higher viral loads than the syncytium-inducing (SI), X4-dependent primary (SF2), T cell-adapted (IIIB) or X4/R5 (Han2, DH12) SI primary isolates.
CONCLUSION: Infection of chimpanzees with NSI R5-utilizing isolates correlated with persistent viraemia (approximately 10(4) RNA equivalents/ml) in contrast to transient viraemia observed after infection with SI X4-utilizing isolates.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11684927     DOI: 10.1097/00002030-200111090-00003

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  9 in total

1.  T cell interleukin-15 surface expression in chimpanzees infected with human immunodeficiency virus.

Authors:  Annette R Rodriguez; Vida Hodara; Kruthi Murthy; LaShayla Morrow; Melissa Sanchez; Amy E Bienvenu; Krishna K Murthy
Journal:  Cell Immunol       Date:  2014-02-06       Impact factor: 4.868

2.  Molecular epidemiology of simian immunodeficiency virus SIVsm in U.S. primate centers unravels the origin of SIVmac and SIVstm.

Authors:  Cristian Apetrei; Amitinder Kaur; Nicholas W Lerche; Michael Metzger; Ivona Pandrea; Johnny Hardcastle; Shelley Falkenstein; Rudolf Bohm; Jeffrey Koehler; Vicki Traina-Dorge; Tessa Williams; Silvija Staprans; Gail Plauche; Ronald S Veazey; Harold McClure; Andrew A Lackner; Bobby Gormus; David L Robertson; Preston A Marx
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Transmission of simian immunodeficiency virus SIVcpz and the evolution of infection in the presence and absence of concurrent human immunodeficiency virus type 1 infection in chimpanzees.

Authors:  Jonathan L Heeney; Erik Rutjens; Ernst J Verschoor; Henk Niphuis; Peter ten Haaft; Scott Rouse; Hazel McClure; Sunita Balla-Jhagjhoorsingh; Willy Bogers; Mary Salas; Kathy Cobb; Luc Kestens; David Davis; Guido van der Groen; Valerie Courgnaud; Martine Peeters; Krishna K Murthy
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys.

Authors:  Ivona Pandrea; Christopher Kornfeld; Mickael J-Y Ploquin; Cristian Apetrei; Abdourahmane Faye; Pierre Rouquet; Pierre Roques; François Simon; Françoise Barré-Sinoussi; Michaela C Müller-Trutwin; Ousmane M Diop
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  High levels of viral replication contrast with only transient changes in CD4(+) and CD8(+) cell numbers during the early phase of experimental infection with simian immunodeficiency virus SIVmnd-1 in Mandrillus sphinx.

Authors:  Richard Onanga; Christopher Kornfeld; Ivona Pandrea; Jerome Estaquier; Sandrine Souquière; Pierre Rouquet; Virginie Poaty Mavoungou; Olivier Bourry; Souleymane M'Boup; Françoise Barré-Sinoussi; François Simon; Cristian Apetrei; Pierre Roques; Michaela C Müller-Trutwin
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

6.  Nef proteins from simian immunodeficiency virus-infected chimpanzees interact with p21-activated kinase 2 and modulate cell surface expression of various human receptors.

Authors:  Frank Kirchhoff; Michael Schindler; Nicola Bailer; G Herma Renkema; Kalle Saksela; Volker Knoop; Michaela C Müller-Trutwin; Mario L Santiago; Frederic Bibollet-Ruche; Matthias T Dittmar; Jonathan L Heeney; Beatrice H Hahn; Jan Münch
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

7.  A dominant block to HIV-1 replication at reverse transcription in simian cells.

Authors:  Carsten Münk; Stephanie M Brandt; Ginger Lucero; Nathaniel R Landau
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-04       Impact factor: 11.205

8.  Effective activation alleviates the replication block of CCR5-tropic HIV-1 in chimpanzee CD4+ lymphocytes.

Authors:  Julie M Decker; Kenneth P Zammit; Juliet L Easlick; Mario L Santiago; Denise Bonenberger; Beatrice H Hahn; Olaf Kutsch; Frederic Bibollet-Ruche
Journal:  Virology       Date:  2009-09-12       Impact factor: 3.616

9.  Simian Immunodeficiency Virus Infection of Chimpanzees (Pan troglodytes) Shares Features of Both Pathogenic and Non-pathogenic Lentiviral Infections.

Authors:  Edward J D Greenwood; Fabian Schmidt; Ivanela Kondova; Henk Niphuis; Vida L Hodara; Leah Clissold; Kirsten McLay; Bernadette Guerra; Sharon Redrobe; Luis D Giavedoni; Robert E Lanford; Krishna K Murthy; François Rouet; Jonathan L Heeney
Journal:  PLoS Pathog       Date:  2015-09-11       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.